Disruption of glomerular cell-cell and cell-matrix interactions in hydrocarbon nephropathy

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Nanez, Adrian ^b   Alejandro, Napoleon F ^a   Falahatpisheh, M Hadi ^b   Kerzee, J Kevin ^a   Roths, John B ^a   Ramos, Kenneth S ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Glomerular diseases; Podocyte proliferation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BENZO[A]PYRENE DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; ENVIRONMENTAL CHEMICAL; FIBRONECTIN; HYDROCARBON; PROTEIN; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CELL SPECIFICITY; CHEMICAL INJURY; CONTROLLED STUDY; FEMALE; IDIOPATHIC DISEASE; KIDNEY DISEASE; MEMBRANE DAMAGE; MESANGIUM CELL; MICROALBUMINURIA; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RAT;

EID: 27944483337     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00107.2005     Document Type: Article

References (58)

1. Alejandro N and Ramos K. Functional, morphological and molecular alterations induced by benzo(a)pyrene in the adult rat. Kidney Toxicol Sci 48: 29, 1999 .
2. Alejandro NF, Parrish AR, Bowes RC, Burghardt RC, and Ramos KS. Phenotypic profiles of cultured glomerular cells following repeated cycles of hydrocarbon injury. Kidney Int 57: 1571-1580, 2000.
3. Alpers C, Hudkins K, Gown A, and Johnson R. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992.
4. Bernard A, de Russis R, Normand J, and Lauwerys R. Evaluation of the subacute nephrotoxicity of cyclohexane and other industrial solvents in the female Sprague-Dawley rats. Toxicol Lett 45: 271-280, 1989.
5. Bertazzi PA, Pesatori AC, Zocchetti C, and Latocca R. Mortality study of cancer risk among oil refinery workers. Int Arch Occup Environ Health 61: 261-270, 1989.
6. Borghoff SJ, Short BG, and Swenberg JA. Biochemical mechanisms and pathobiology of 2u-globulin nephropathy. Annu Rev Pharmacol Toxicol 30: 349-367, 1990.
7. Bowes IHR and Ramos K. Assessment of cell-specific cytotoxic responses of the kidney to selected aromatic hydrocarbons. Toxicol In Vitro 8: 1151-1160, 1994.
8. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1973.
9. Brauze D, Mikstacka R, and Baer-Dubowski W. Formation and persistence of benzo[a]pyrene-DNA adducts in different tissues of C57B1/10 and DBA/2 mice. Carcinogenesis 12: 1607-1611, 1991 .
10. Brune H, Deutsch-Wenzel RP, Habs M, Ivankovic S, and Schmahl D. Investigation of the tumorigenic response to benzo(a)pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. J Cancer Res Clin Oncol 102: 153-157, 1981.
11. Cameron JS. The natural history of glomerulonephritis. In: Progress in Glomerulonephritls, edited by Kincade-Smith IN, d'Apice AJF, and Atkins RC. New York: John Wiley and Sons, p. 1-25.
12. Choi HJ, Hyun M, Jung G, Kim S, and Hong SH. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 55: 575-581, 1998.
13. Coleman N and Stanley M. Expression of the myelomonocytic antigens CD36 and L1 by keratinocytes in squamous intraepithelial lesions of the cervix. Hum Pathol 25: 73-79, 1994.
14. Crocker T, Nielsen B, and Lasnitzki I. Carcinogenic hydrocarbons: effects on suckling rat trachea in organ culture. Arch Environ Health 10: 240-250, 1965.
15. Cunha G. Role of the mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74: 1030-1044, 1994.
16. Elseviers M and De Broe M. Epidemiology of toxic nephropathies. Adv Nephrol Necker Hasp 27: 241-262, 1997.
17. Floege J, Johnson R, Alpers C, Fatemi-Nainie S, Richardson C, Gordon K, and Couser W. Visceral glomerular epithelial cells can proliferate in vivo and synthesize PDGF B chain. Am J Pathol 142: 637-650, 1993.
18. Glassock R, Cohen A, and Adler S. Primary glomerular diseases. In: The Kidney, edited by Brenner B. Philadelphia: W. B. Sanders, 1996, p. 1392-1497.
19. Ha H and Lee HB. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58: 19-25, 2000.
20. Han G, Koike H, Nakatsue T, Suzuki K, Yoneyama H, Narumi S, Kobayashi N, Mundel P, Shimizu F, and Kawachi H. IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulohephritis. J Am Soc Nephrol 14: 1-27, 2003.
21. Hayward S, Grossfeld G, Tlsty T, and Cunha G. Genetic and epigenetic influences in prostatic carcinogenesis. Int J Oncol 13: 35-47, 1998.
22. Holthofer H, Sainio K, and Miettinen A. The glomerular mesangium: studies of its developmental origin and markers in vivo and in vitro. APMIS 103: 354-366, 1995.
23. Hotz P. Occupational hydrocarbon exposure and chronic nephropathy. Toxicology 90: 163-283, 1994.
24. Hricik DE, Chung-Park M, and Sedor JR. Glomerulonephritis. N Engl J Med 339: 888-899, 1998.
25. Idelson RA, Smithline N, Smith GW, and Harrinton JT. Prognosis in steroid-treated idiopathic nephrotic syndrome in adults: analysis of major predictive factors after 10-year follow-up. Arch Intern Med 137: 891-896, 1977.
26. Kawada N, Moriyama T, Ando A, Koyama T, Hori M, Miwa T, and Imai E. Role of intron 1 in smooth muscle α-actin transcriptional regulation in activated mesangial cells in vivo. Kidney Int 55: 2338-2348, 1999.
27. Kerzee K and Ramos K. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHIH/PAS transcription factor. Circ Res 89: 563-565, 2001.
28. Kim K and Lee B. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo(a)pyrene. Cancer Lett 113: 205-212, 1997.
29. Knuckles ME, Inyang F, and Ramesh A. Acute and subchronic oral toxicities of benzo[a]pyrene in F-344 rats. Toxicol Sci 61: 382-388, 2001.
30. Kriz W, Gretz N, and Lemley K. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54: 687-697, 1998.
31. Kurogi Y. Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 23: 15-31, 2003.
32. Lee HB, Yu MR, Yang Y, Jiang Z, and Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol-14: S241-S245, 2003.
33. Lees G, Wilson P, Helman R, Homco L, and Frey M. Glomerular ultrastructure findings similar to hereditary nephritis in 4 English Cocker Spaniels. J Vet Intern Med 11: 80-85, 1997.
34. Lehman-McKeeman LD, Rodriguez PA, Takigiku R, Caudill D, and Fey ML. D-Limonene-induced male rat-specific nephrotoxicity: evaluation of the association between D-limonene and α2u-globulin. Toxicol Appl Phamacol 99: 250-290, 1989.
35. Lock EA, Charbonneau M, Strasser J, Swenberg JA, and Bus JS. 2,2,4-Trimethylpentane-induced nephrotoxicity. II. The reversible binding of a TMP metabolite to a renal protein fraction containing alpha 2u-globulin. Toxicol Appl Pharmacol 91: 182-192, 1987.
36. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, and Doi T. A vitamin D analog amelioratesglomerular injury on rat glomerulonephritis. Am J Pathol 158: 1733-1741, 2001.
37. Marshall T and Williams K. Simplified sodium dodecyl sulfate- polyacrylamide gel electrophoresis of unconcentrated urine with enhanced resolution and detection sensitivity. Clin Chem 33: 1886-1887, 1987.
38. Mathieson PW. The cellular basis of albuminuria. Clin Sci (Colch) 107: 533-538, 2004.
39. Miller K and Ramos K. Impact of metabolism on the biological effects of benzo(a)pyrene and related hydrocarbons. Drug Metab Rev 33: 1-35, 2001.
40. Minto A, Kalluri R, Togawa M, Bergijk E, Killen P, and Salant DJ. Augmented expression of glomerular basement membrane specific type IV collagen isoforms (α3-α5) in experimental membranous nephropathy. Proc Assoc Am Physicians 110: 207-217, 1998.
41. Mizuno S, Yue B, Okamoto M, Horikawa Y, and Kurosawa T. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol 5: 498-507, 1997.
42. Pai P, Hindell P, Stevenson A, Mason H, and Bell G. Genetic variants of microsomal metabolism and susceptibility to hydrocarbon-associated glomerulonephritis. QJM 90: 693-698, 1997.
43. Parrish A, Alejandro N, Bowes R III, and Ramos K. Cytotoxic response profiles of cultured renal epithelial and mesenchymal cells to selected aromatic hydrocarbons. Toxicol In Vitro 12: 219-232, 1998.
44. Parrish AR, Alejandro NF, Bral CM, Kevin Kerzee J, Bowes I, Russell C, and Ramos KS. Characterization of glomerular cell phenotypes following repeated cycles of benzo[a]pyrene injury in vitro. Biochem Pharmacol 64: 31-39, 2002.
45. Pinto-Sietsma S, Mulder J, Janssen W, Hillege H, de Zeeuw D, and de Jong P. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133: 585-591, 2000.
46. Ranieri E, Gesualdo L, Grandaliano G, Maiorano E, and Schena F. The role of α-smooth muscle actin and platelet-derived growth factor-β receptor in the progression of renal damage in human IgA nephropathy. J Nephrol 14: 253-262, 2001.
47. Reiner J, Jones C Jr, Hong N, and Myrand S. Differential induction of cyp1A1, cyp1B1, ahd4, and nmol in murine skin tumors and adjacent normal epidermis by ligands of the aryl hydrocarbon receptor. Mol Carcinog 21: 135-146, 1994.
48. Reinhard M, Hottendorf G, and Powell E. Differences in the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicity. Toxicol Pathol 19: 66-71, 1991.
49. Robertson J. Chemically induced glomerular injury: a review of basic mechanisms and specific xenobiotics. Toxicol Pathol 26: 64-72, 1998.
50. Rowley D, Dang T, Larsen M, Gerdes M, McBride L, and Lu B. Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J Biol Chem 270: 22058-22065, 1998.
51. Salant O. The structural biology of glomerular epithelial cells in proteinuric diseases. Curr Opin Nephrol Hypertens 3: 569-574, 1994.
52. Sato N, Komatsu K, and Kurumatani H. Late onset of diabetic nephropathy in spontaneously diabetic GK rats. Lab Invest 23: 334-342, 2003.
53. Swenberg JA, Short B, Borghoff S, Strasser J, and Charbonneau M. The comparative pathobiology of α2u-globulin nephropathy. Toxicol Appl Pharmacol 97: 35-46, 1989.
54. Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, and Nagy J. Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22: 161-168, 1997.
55. Wang D, Yang J, and Wang P. The interaction of glomerular mesangial cells and epithelial cells. Pediatr Nephrol 12: 197-200, 1998.
56. Williams PS, Fass G, and Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. QJM 67: 343-354, 1954.
57. Yoshioka T, Ichikawa I, and Fogo A. Reactive oxygen metabolites causes massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2: 902-912, 1991.
58. Zeller R. Fixation, Embedding, and Sectioning of Tissues, Embryos, and Single Cells. New York: Wiley, 1996.